Title
Category
Credits
Event date
Cost
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial products for cancer patients.  This lecture will review the current treatments and their use in patients with hematologic malignancies.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
The presentation will provide an overview of Integrative Medicine (IM) and Lifestyle Medicine for oncology patients, including definitions of IM, integrative oncology, and lifestyle medicine as they relate to the care of oncology patients.  Specific strategies that may be incorporated to enhance the care of those affected by cancer will be highlighted, along with a description of the Integrative Medicine Consultative Service through the Comprehensive Cancer Support Program (CCSP).  Additional resources/w
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cancer. We will also review the impact of the pandemic on cancer care delivery, and emerging data regarding vaccination safety and efficacy.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This is a case-based lecture to cover the common side effects and rare but important side effects of check point inhibitors and other immunotherapy agents.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leading to low platelets, though the mechanism by which the platelets are consumed differs.  The lecture will update viewers on new therapies for the treatment of ITP and TTP
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
In this presentation, Dr. Bryant will share strategies in collaborating with team members in both the inpatient and outpatient settings to optimize cancer care.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
Wendell Yarbrough, MD, MMHC, FACS, will lecture on multi-disciplinary treatment of head and neck cancer with updates regarding new techniques and treatment standards. This lecture will also give the audience updates on HPV-Associated Head and Neck Cancer with emerging therapeutic vulnerabilities. 
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This talk aims to provide a general background on the breadth and application of genetic testing in cancer patients. We will also provide strategies for communicating with patients about the necessity and utilization of testing, by presenting sample patient cases to demonstrate these approaches.
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • ASRT
  • NCPD/CNE
  • Participation
$0.00
This lecture is an interactive presentation and discussion to consider barriers to cancer clinical trial enrollment in North Carolina and potential approaches to address this. Topics will include the importance of patient and provider engagement, education and resources for identifying research opportunities and available trials, barriers and mitigation strategies to address population disparities in trial enrollment, and other issues.

Pages